Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
GLPG similar filings
- 12 Jun 23 Current report (foreign)
- 25 May 23 Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with dermatomyositis
- 23 May 23 Galapagos demonstrates commitment to immunology with new data in rheumatoid arthritis at EULAR 2023
- 9 May 23 Galapagos creates new subscription right plans
- 5 May 23 Galapagos announces first quarter 2023 financial results
- 2 May 23 Galapagos announces departure of Bart Filius, Chief Operating Officer and Chief Financial Officer
- 2 May 23 Current report (foreign)
Filing view
External links